ASVRX
Price
$11.34
Change
-$0.07 (-0.61%)
Updated
Nov 13 closing price
AVUVX
Price
$18.92
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Ad is loading...

ASVRX vs AVUVX

Header iconASVRX vs AVUVX Comparison
Open Charts ASVRX vs AVUVXBanner chart's image
American Century Small Cap Value R
Price$11.34
Change-$0.07 (-0.61%)
VolumeN/A
CapitalizationN/A
Avantis® U.S. Small Cap Value Instl
Price$18.92
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ASVRX vs AVUVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASVRX vs. AVUVX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Buy and AVUVX is a StrongBuy.

FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 5.89B vs. AVUVX (974M). AVUVX pays higher dividends than ASVRX: AVUVX (1.49) vs ASVRX (0.47). ASVRX was incepted earlier than AVUVX: ASVRX (15 years) vs AVUVX (5 years). ASVRX is a more actively managed with annual turnover of: 44.00 vs. AVUVX (22.00). ASVRX has a lower initial minimum investment than AVUVX: ASVRX (2500) vs AVUVX (5000000). AVUVX annual gain was more profitable for investors over the last year : 39.16 vs. ASVRX (34.48).
ASVRXAVUVXASVRX / AVUVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years5 years-
Gain YTD13.16017.88674%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.89B974M605%
Annual Yield % from dividends0.471.4932%
Returns for 1 year34.4839.1688%
Returns for 3 years-1.7519.33-9%
Returns for 5 years51.86N/A-
Returns for 10 years20.54N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALLIX117.370.09
+0.08%
AB Large Cap Growth I
MEYWX13.28N/A
N/A
Manning & Napier Equity Series W
CVTCX51.34-0.15
-0.29%
Calamos Growth & Income C
MWOHX65.86-0.38
-0.57%
MFS Global Growth R3
DRLAX8.80-0.11
-1.23%
BNY Mellon Developed Markets RE Scs - A